Skip to main content
    M

    McKesson Corporation (MCK)

    Official site

    HEALTHCARE • MEDICAL DISTRIBUTION • NYSE

    $1105.15
    +2.34 (+0.21%)

    Market Cap: $127.33B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    McKesson Corporation (MCK) Earnings: Report Dates and Results

    Updated Nov 4, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    McKesson (MCK) is expected to report earnings on Feb 2, 2027. In the quarter ended Sep 30, 2026, McKesson reported EPS of $11.68, above the $10.69 estimate. It beat the EPS estimate in each of the last 10 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    85%(34/40)
    Avg Surprise
    +7.51%
    Streak
    10 Q

    Upcoming Estimates

    Reports Feb 2, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus$10.95
    Range$10.49 - $11.71
    10 analysts
    EPS Revisions
    0
    4
    30d
    EPS Estimate DriftChange to current
    90d ago$10.96-0.1%
    60d ago$10.97-0.2%
    30d ago$10.96-0.1%
    7d ago$10.90+0.5%
    Current$10.95
    Revenue Consensus
    $114.02B
    Range$112.81B - $115.43B
    10 analysts
    Reports May 5, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus$13.71
    Range$12.43 - $15.01
    17 analysts
    Revenue Consensus
    $105.60B
    Range$100.94B - $113.59B
    15 analysts

    Next Report

    MCK has an expected report date of Feb 2, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 17.2% above the $9.34 reported for the quarter ended Dec 31, 2025.

    MCK Earnings Call

    The latest MCK earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 40 quarters below that had an estimate, MCK beat 34, missed 5 and matched 1. Revenue for the quarter ended Sep 30, 2026 was $110.96B, up 7.6% from $103.15B a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026$11.68$10.69$10.53 - $11.26+9.26%Beat+18.5%151 up, 0 downNov 4, 2026$110.96B
    Jun 30, 2026$9.93$9.44$9.25 - $9.89+5.19%Beat+20.2%150 up, 4 downAug 5, 2026$105.38B
    Mar 31, 2026$11.69$11.57$11.45 - $11.67+1.04%Beat+15.5%161 up, 0 downMay 7, 2026$96.30B
    Dec 31, 2025$9.34$9.27$9.05 - $10.01+0.76%Beat+16.3%152 up, 2 downFeb 4, 2026$106.16B
    Sep 30, 2025$9.86$8.92$8.53 - $9.49+10.54%Beat+39.5%142 up, 3 downNov 5, 2025$103.15B
    Jun 30, 2025$8.26$8.15$7.78 - $8.49+1.35%Beat+4.8%120 up, 5 downAug 6, 2025$97.83B
    Mar 31, 2025$10.12$9.83$9.67 - $9.96+2.95%Beat+63.8%143 up, 1 downMay 8, 2025$90.82B
    Dec 31, 2024$8.03$7.99$7.82 - $8.24+0.50%Beat+3.7%140 up, 7 downFeb 5, 2025$95.29B
    Sep 30, 2024$7.07$6.87$6.76 - $7.03+2.91%Beat+13.5%151 up, 1 downNov 6, 2024$93.65B
    Jun 30, 2024$7.88$7.21$7.10 - $7.38+9.29%Beat+8.4%154 up, 0 downAug 7, 2024$79.28B
    Mar 31, 2024$6.18$6.36$6.20 - $6.68-2.83%Miss-14.0%152 up, 1 downMay 7, 2024$76.36B
    Dec 31, 2023$7.74$7.05$6.85 - $7.29+9.79%Beat+12.2%146 up, 0 downFeb 7, 2024$80.90B
    Sep 30, 2023$6.23$6.15$5.96 - $6.26+1.30%Beat+2.8%121 up, 1 downNov 1, 2023$77.22B
    Jun 30, 2023$7.27$5.87$5.73 - $6.05+23.85%Beat+24.7%131 up, 1 downAug 2, 2023$74.48B
    Mar 31, 2023$7.19$7.12$7.05 - $7.30+0.98%Beat+23.3%141 up, 0 downMay 8, 2023$68.91B
    Dec 31, 2022$6.90$6.36$6.24 - $6.51+8.49%Beat+12.2%122 up, 1 downFeb 1, 2023$70.49B
    Sep 30, 2022$6.06$6.10$5.89 - $6.45-0.66%Miss-1.5%124 up, 0 downNov 1, 2022$70.16B
    Jun 30, 2022$5.83$5.30$5.18 - $5.35+10.00%Beat+4.9%124 up, 0 downAug 3, 2022$67.15B
    Mar 31, 2022$5.83$6.04$5.83 - $6.35-3.48%Miss+15.4%121 up, 1 downMay 5, 2022$66.10B
    Dec 31, 2021$6.15$5.42$5.02 - $5.89+13.47%Beat+33.7%1210 up, 0 downFeb 2, 2022$68.61B
    Sep 30, 2021$6.15$4.66$4.50 - $5.08+31.97%Beat+28.1%12N/ANov 1, 2021$66.58B
    Jun 30, 2021$5.56$4.14$3.28 - $4.43+34.30%Beat+100.7%12N/AAug 4, 2021$62.67B
    Mar 31, 2021$5.05$5.05$4.93 - $5.190.00%In line+18.3%14N/AMay 6, 2021$59.14B
    Dec 31, 2020$4.60$4.13$3.98 - $4.28+11.38%Beat+20.7%16N/AFeb 2, 2021$62.60B
    Sep 30, 2020$4.80$3.88$3.74 - $4.09+23.71%Beat+33.3%15N/ANov 3, 2020$60.81B
    Jun 30, 2020$2.77$2.39$1.96 - $2.50+15.90%Beat-16.3%14N/AAug 3, 2020$55.68B
    Mar 31, 2020$4.27$4.10$3.87 - $4.20+4.15%Beat+15.7%15N/AMay 20, 2020$58.53B
    Dec 31, 2019$3.81$3.49$3.47 - $3.78+9.17%Beat+12.1%10N/AFeb 4, 2020$59.17B
    Sep 30, 2019$3.60$3.59$3.50 - $3.69+0.28%Beat0.0%15N/AOct 30, 2019$57.62B
    Jun 30, 2019$3.31$3.01$2.85 - $3.14+9.97%Beat+14.1%14N/AJul 31, 2019$55.73B
    Mar 31, 2019$3.69$3.66$3.60 - $3.71+0.82%Beat+5.7%15N/AMay 8, 2019$52.43B
    Dec 31, 2018$3.40$3.16$3.00 - $3.30+7.59%Beat-0.3%16N/AJan 31, 2019$56.21B
    Sep 30, 2018$3.60$3.28$3.13 - $3.53+9.76%Beat+9.8%16N/AOct 25, 2018$53.08B
    Jun 30, 2018$2.90$2.89$2.73 - $2.95+0.35%Beat+17.9%15N/AJul 26, 2018$52.61B
    Mar 31, 2018$3.49$3.56$3.35 - $3.66-1.97%Miss+2.0%16N/AMay 24, 2018$51.63B
    Dec 31, 2017$3.41$2.95$2.82 - $3.15+15.59%Beat+11.8%15N/AFeb 1, 2018$53.62B
    Sep 30, 2017$3.28$2.79$2.59 - $2.90+17.56%Beat+11.6%12N/AOct 26, 2017$52.06B
    Jun 30, 2017$2.46$2.83$2.72 - $2.89-13.07%Miss-29.7%16N/AJul 27, 2017$51.05B
    Mar 31, 2017$3.42$3.01$2.91 - $3.10+13.62%Beat+7.9%14N/AMay 18, 2017$48.71B
    Dec 31, 2016$3.05$2.91N/A+4.81%Beat-4.1%N/AN/AJan 25, 2017$50.13B
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Mar 31, 2026 was $39.15, up 18.3% from the year before. It was $12.91 for the year ended Mar 31, 2017, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Mar 31, 2026$39.15+18.3%
    Mar 31, 2025$33.10+20.7%
    Mar 31, 2024$27.42+5.5%
    Mar 31, 2023$25.98+9.7%
    Mar 31, 2022$23.69+37.6%
    Mar 31, 2021$17.22+14.9%
    Mar 31, 2020$14.99+10.3%
    Mar 31, 2019$13.59+7.5%
    Mar 31, 2018$12.64-2.1%
    Mar 31, 2017$12.91N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 6,400 words across 15 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20266,36815
    2026Q2Jun 30, 20268,23317
    2026Q1Mar 31, 20267,62915
    2025Q4Dec 31, 20258,81213
    2025Q3Sep 30, 20258,38616
    2025Q2Jun 30, 20259,33217
    2025Q1Mar 31, 20258,15514
    2024Q4Dec 31, 20248,03115

    2026Q3 Earnings Call

    Opening remarks

    Jeni Dominguez VP of Investor Relations Thank you, operator. Good afternoon, and welcome, everyone, to McKesson Corporation's Third Quarter Fiscal 2026 Earnings Call. Today, I'm joined by Brian Tyler, our Chief Executive Officer, and Britt Vitalone, our Chief Financial Officer. Brian will speak first, followed by Britt, and then we'll move to a question and answer session. Today's discussion will include forward-looking statements such as forecasts about McKesson Corporation's operations and future results. Please refer to the cautionary statements in today's earnings release and presentation slides available on our website at investors.mckesson.com and to the Risk Factors section of our most recent annual and periodic SEC filings for additional information concerning risk factors that could cause our actual results to materially differ from those in our forward-looking statements. Information about non-GAAP financial measures that we will discuss during this webcast, including a reconciliation of those measures to GAAP results, can be found in today's earnings release and presentation slides. The presentation slides also include a summary of our results for the quarter and guidance assumptions. With that, let me turn it over to Brian.

    Brian Tyler Chief Executive Officer Thank you, Jeni. Good afternoon, everyone. Appreciate you joining McKesson Corporation's fiscal third quarter earnings call. Today's results once again demonstrate the strength and durability of our business. Revenue and adjusted EPS grew double digits driven by continued momentum across oncology, biopharma services, and North American distribution. The consistency of this performance gives us the confidence to raise full-year EPS guidance to a range of $38.80 to $39.20, which reflects 17 to 19% year-over-year growth. I want to thank team McKesson for their unwavering commitment to excellence and innovation, driving tangible impacts every day for our stakeholders and keeping patients at the center of everything that we do. Today, my remarks will focus on the continued progress of our company priorities and the momentum we are driving across the organization and, of course, recognizing the dedication and engagement across team McKesson. Then, as is customary, I'll hand it over to Britt for a more detailed review of the financials. So let me start where I usually do with our people and our culture. We aspire to be the best place to work in health care, and supporting our employees' growth and success remains a top priority. Our employee resource groups play a critical role in strengthening connections and reinforcing our culture of care and belonging. These employee-led networks empower colleagues to come together to advance the business and to build an environment where everyone can thrive. This year, we're pleased to see membership of more than 30%. Participation in these groups results in increased employee engagement, improved retention, and better business outcomes.

    Frequently Asked Questions About MCK

    When is McKesson's next earnings date?

    McKesson's next earnings report is expected for Feb 2, 2027.

    Did MCK beat earnings estimates last quarter?

    Yes. McKesson reported EPS of $11.68 for the quarter ended Sep 30, 2026, above the $10.69 estimate, a 9.26% surprise.

    What EPS do analysts expect from MCK next quarter?

    The consensus EPS estimate for McKesson for the quarter ending Dec 31, 2026 is $10.95 from 10 analysts, with estimates from $10.49 to $11.71.

    How often does MCK beat earnings estimates?

    McKesson beat the EPS estimate in each of the last 10 quarters, with an average surprise of +4.38%.